US Patent Issued to Elixirgen Therapeutics on Nov. 25 for "Methods of using Zscan4 for rejuvenating human cells" (Maryland Inventor)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,657, issued on Nov. 25, was assigned to Elixirgen Therapeutics Inc. (Baltimore).

"Methods of using Zscan4 for rejuvenating human cells" was invented by Minoru S.H. Ko (Cockeysville, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to methods for increasing telomere length in one or more human cells and/or increasing genome stability of one or more human cells, for example by contacting one or more human cells with an agent that increases expression of Zscan4 in the one or more human cells. Methods of treating a subject in need of telomere lengthening, treating a disease or condition associated with a genomic and/or c...